![Bo I. Nilsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Bo I. Nilsson
Anciens postes connus de Bo I. Nilsson
Sociétés | Poste | Début | Fin |
---|---|---|---|
Unibioscreen SA
![]() Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Directeur Technique/Scientifique/R&D | 11/06/2010 | 10/05/2011 |
WEIFA ASA | Corporate Officer/Principal | 01/05/2007 | 10/06/2010 |
Statistiques
Internationale
Norvège | 2 |
Belgique | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Weifa ASA
![]() Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
Unibioscreen SA
![]() Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
- Bourse
- Insiders
- Bo I. Nilsson
- Expérience